These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 31884151
1. Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant. Fergadis E, Assi A, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, Dimitriadis GK, Grivas A, Athanasopoulos A, Lianos E, Kosmas C. Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):e50-e57. PubMed ID: 31884151 [Abstract] [Full Text] [Related]
3. Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts. Holmberg LA, Linenberger M, Connelly-Smith L. Transplant Cell Ther; 2022 Nov; 28(11):754-759. PubMed ID: 36002104 [Abstract] [Full Text] [Related]
4. Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience. Malinowska I, Romiszewski M, Smalisz K, Stelmaszczyk-Emmel A, Nasilowska-Adamska B, Krol M, Urbanowska E, Brozyna A, Baginska-Dembowska B. Transfus Apher Sci; 2021 Jun; 60(3):103077. PubMed ID: 33583716 [Abstract] [Full Text] [Related]
9. First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients. Bekadja MA, Mansour B, Ouldjeriouat H, Entasoltan B, Bouchama S, Charef L, Amani K, Hakiki N, Bouamama F, Osmani S, Brahimi M, Arabi A, Bouhass R, Yafour N. Transfus Apher Sci; 2021 Jun; 60(3):103070. PubMed ID: 33612450 [Abstract] [Full Text] [Related]
18. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor. Yuan S, Palmer JM, Tsai NC, Dagis A, Nademanee A, Wang S. Hematol Oncol; 2017 Sep; 35(3):281-287. PubMed ID: 26928577 [Abstract] [Full Text] [Related]